Open

Coming up

Don't miss

Replay


LATEST SHOWS

THE INTERVIEW

Tunisia’s Essebsi ‘personifies old regime’, says opponent Marzouki

Read more

DEBATE

After Ferguson: What's Broken in America?

Read more

THE INTERVIEW

David Nabarro, UN special envoy on Ebola

Read more

THE INTERVIEW

Tunisia’s Essebsi says ready to form pluralist govt

Read more

WEB NEWS

USA: online reactions to the death of Tamir Rice

Read more

FOCUS

Working with offenders also key to ending domestic violence

Read more

ENCORE!

Man Booker Prize Winner Eleanor Catton

Read more

BUSINESS DAILY

Who makes money from France's Christmas markets?

Read more

LIFESTYLES

Changing cheese culture

Read more

France

France gives go-ahead to cannabis-based drug

© GW Pharmaceuticals

Text by FRANCE 24

Latest update : 2014-01-09

France’s health ministry announced Thursday it had approved the use of Sativex, a cannabinoid mouth spray, to treat patients suffering from multiple sclerosis (MS). The drug is the first marijuana-based medicine to be made available in the country.

While the decision to approve Sativex may seem revolutionary for France, the prescription of the drug will be extremely limited. The spray will only be recommended for MS patients with “severe muscle spasms (spasticity), resistant to other treatments,” according to the health ministry, which also specified that only neurologists and physical therapists will have the right to prescribe it at first.

Once on the market, Sativex can prescribed for up to six months, the national health monitoring agency (which approved the drug and set its conditions of use) told French daily Le Monde in a statement. The medication will be available at pharmacies, where it will be stocked in a safe with other opiate-based drugs.

French Health Minister Marisol Touraine first raised the issue of approving cannabis-based medications in June, when she signed an order authorising the national health agency to look at requests to commercialise such products. Although many countries – including Holland, Canada, Germany, Britain and even some US states – already allow the use of medical marijuana, France has been hesitant to embrace the drug’s therapeutic properties until now.

Sativex, which is made by the British company GW Pharmaceuticals and has already been approved in more than 20 countries, still has a few hoops to jump through before hitting the French market. It must go through the country’s highest health body before a price and reimbursement rate can be decided. The drug is expected to be made available in 2015.

(FRANCE 24 with AFP)

Date created : 2014-01-09

  • USA

    Marijuana shops open in Colorado

    Read more

  • URUGUAY

    Uruguay votes to legalise marijuana production

    Read more

  • USA

    Californians reject proposal to legalise marijuana

    Read more

COMMENT(S)